STOCK TITAN

Atlantic Coastal Acquisition Corp. Ii SEC Filings

ACABU NASDAQ

Welcome to our dedicated page for Atlantic Coastal Acquisition Ii SEC filings (Ticker: ACABU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

SPAC paperwork can feel like a maze of redemption deadlines, warrant adjustments, and merger math. Atlantic Coastal Acquisition Corp. II SEC filings explained simply is what most shareholders search for after hearing about the $725 million Abpro deal. Whether you need the first S-4 proxy outlining dilution, or the latest 8-K material events explained, our platform turns dozens of exhibits into plain-English insights within seconds.

How Stock Titan’s AI helps:

  • Atlantic Coastal Acquisition Corp. II quarterly earnings report 10-Q filing distilled into cash-in-trust trends
  • Atlantic Coastal Acquisition Corp. II insider trading Form 4 transactions flagged the moment they post
  • Real-time alerts for Atlantic Coastal Acquisition Corp. II Form 4 insider transactions real-time and warrant exercises
  • Atlantic Coastal Acquisition Corp. II annual report 10-K simplified with side-by-side KPI charts
  • understanding Atlantic Coastal Acquisition Corp. II SEC documents with AI through concise section-by-section summaries

Need the numbers behind the merger vote? Our AI-powered summaries surface trust-redemption ratios, sponsor promote terms, and Atlantic Coastal Acquisition Corp. II proxy statement executive compensation details without hunting through PDFs. Quickly pivot to Atlantic Coastal Acquisition Corp. II earnings report filing analysis, or monitor Atlantic Coastal Acquisition Corp. II executive stock transactions Form 4 before key announcements. All filings—10-K, 10-Q, 8-K, S-4, SC 13G—arrive from EDGAR in real time, ready for search, highlight, and export. From pipeline milestones to dilution scenarios, every disclosure lives here so you can act with confidence.

Rhea-AI Summary

Abpro Holdings, Inc. filed a preliminary proxy describing its 2025 Annual Meeting matters, including three proposals: elect one Class I director, ratify the selection of Wolf & Company, P.C. as independent registered public accounting firm, and approve a 1-for-10 reverse stock split. The proxy identifies Ian McDonald as the Class I nominee and confirms he is currently a director and willing to serve if elected. Management is Miles Suk, Chief Executive Officer and Chairman.

The filing discloses a restatement of consolidated financial statements for periods ended Sep 30, 2024 and Dec 31, 2023 and 2022 to correct accrued expenses, total liabilities and accumulated deficit balances; the audit committee met twice in 2024 after the business combination closed on Nov 13, 2024, and identified material weaknesses including failure to timely file tax returns and over-accrual of expenses. The compensation committee was formed at closing and did not meet in 2024. The proxy explains voting procedures, broker discretionary voting (routine proposals 2 and 3), and distributions of proxy materials and the annual report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
proxy
-
Rhea-AI Summary

Abpro Holdings, Inc. reported a net loss of $2.984 million for the three months and $6.871 million for the six months ended June 30, 2025. The company held $2.014 million of cash and $3.483 million of total assets at June 30, 2025, against $20.430 million of current liabilities, producing a materially negative working capital position and an accumulated deficit of $122.974 million.

Management disclosed substantial doubt about the company's ability to continue as a going concern for the next 12 months without additional financing. The company completed a reverse recapitalization and related PIPE financing that produced $5,700, and received $1,840 in net proceeds from a SEPA second convertible note on June 23, 2025. Nasdaq notified the company of deficiencies for the minimum bid price and market-value tests and provided compliance periods through September 29, 2025 and October 7, 2025. As of August 11, 2025 the filing reports issued and outstanding common shares of 81,150,000 and 80,166,667, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
registration
Atlantic Coastal Acquisition Corp. Ii

NASDAQ:ACABU

ACABU Rankings

ACABU Stock Data

30.00M
0%
Shell Companies
Biological Products, (no Disgnostic Substances)
United States
NEW YORK